Sangamo Therapeutics Inc (SGMO) — Cash Flow Quality Index

Latest as of September 2024: 1.10x

Sangamo Therapeutics Inc (SGMO) has a Cash Flow Quality Index of 1.10x as of September 2024. Operating cash flow of $11.76 Million exceeds net income of $10.67 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Sangamo Therapeutics Inc to assess how effectively this company generates cash.

Cash Flow Quality Index

1.10x

Operating CF / Net Income

Operating Cash Flow

$11.76 Million

USD

Net Income

$10.67 Million

USD

Data as of

Sep 2024

Most recent filing

Annual Cash Flow Quality Index for Sangamo Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Sangamo Therapeutics Inc. For live market cap and the full company financial profile, see Sangamo Therapeutics Inc (SGMO) total market value.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.